Rather than focusing on a single biological process, researchers are studying BPC-157 across multiple experimental models to better understand its interactions with tissue biology, cellular signaling, and vascular function
A subcutaneous injection, which goes into the fatty tissue just beneath the skin, provides a slower, more gradual release
Dosing charts are concentration-specific
In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes
